If your treatment raises GAPDH by half, every target you normalize to it looks a third lower, even if nothing changed. Few labs check: studies use 1.2 reference genes on average, and only 15% test a panel first. This guide covers choosing candidates from different pathways, validating them with geNorm and NormFinder, and what MIQE 2.0 now asks you to report.
